Despite these limitations, our study identifies seven core targets (HSP90AB1, CCNB1, CCK, CDK6, CASP9, NR3C1, and ERBB2) that offer promising avenues for developing novel asthma therapies. The gene discussed is HSP90AB1; the disease is asthma.